NLS Pharmaceutics AG (NLSPW)
undefined
undefined%
At close: undefined
0.01
0.00%
After-hours Dec 13, 2024, 03:41 PM EST

Ratios (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -18.44 -15.39 -13.70 -48.67 -59.11 -66.14 -51.14
PS Ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PB Ratio -25.41 77.39 301.83 -15.50 -52.18 -38.62 -44.11
P/FCF Ratio -23.18 -18.29 -10.93 -190.95 -1694.65 -124.57 -62.66
P/OCF Ratio -23.18 -18.29 -10.96 -190.95 -1694.65 -124.57 -62.66
OCF/S Ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt / Equity Ratio -0.05 0.00 0.00 -0.06 -0.03 -0.20 -0.29
Quick Ratio 0.06 0.69 0.60 0.01 0.02 0.01 0.57
Current Ratio 0.06 0.69 0.60 0.01 0.02 0.01 0.57
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest Coverage -20.34 -38.37 -43.52 -2.46 -1.28 -0.81 -1.62
Return on Equity (ROE) 137.79% -502.79% -2202.50% 31.85% 88.27% 58.40% 86.26%
Return on Assets (ROA) -659.14%-177.82%-207.23%-236.17%-782.15%-3534.02%-290.94%
Return on Capital (ROIC) 194.42%-261.66%-352.86%38.37%125.71%151.99%-444.20%
Dividend Yield 0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Payout Ratio 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Gross Profit Margin 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Profit Margin 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%